SUMMARY The effect of captopril mediated afterload reduction on aortic regurgitation was investigated in 10 patients. Regurgitation was quantitated by means of the regurgitation fraction and the relation of regurgitant volume to end diastolic volume. These variables were derived from gated radionuclide ventriculography. After captopril treatment the blood concentration of angiotensin I rose whereas that of angiotensin II fell significantly. The conversion of angiotensin I to II was reduced to about 50% of the control value. Whereas blood pressure and heart rate did not change significantly, the regurgitation fraction and the regurgitant volume, normalised to end diastolic volume, were significantly reduced by captopril treatment. The ejection fraction remained essentially unchanged. These findings suggest that captopril reduces aortic regurgitation by reducing afterload.
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In chronic aortic insufficiency there is long standing volume overload of the left heart chamber. The Renin-angiotensin measurements-Angiotensin I and II and the activity of angiotensin converting enzyme activity were measured by radioimmunoassay or spectrophotometry.8 Blood pressure (Riva-Rocci) was measured repeatedly before and after captopril. The average heart rate during radionuclide ventriculography was calculated from the representative heart cycle (see below) before and after captopril.
Gated radionuclide ventriculography-In all patients electrocardiogram gated equilibrium radionuclide ventriculography was performed after injection of 20 mCi of technetium-99m labelled autologuous red blood cells. Data in list mode were acquired by means of a LFOV gamma camera connected to a minicomputer. A hardware zoom of 1-5 was applied. Data were collected from the best septal view (30°to 450 left anterior oblique). A high resolution collimator was used. Ten million counts were collected per study. The statistical distribution of the different cardiac cycle lengths during data acquisition was determined and a representative cardiac cycle-usually the one which occurred most frequently-was automatically selected. The cumulative frame sequence was generated exclusively from cycles which fell into the selected range. A frame rate of 50 frames per second was used. The frame size was 64 x 64 pixels. Data on 300 to 500 heart cycles were accumulated per study. End diastolic and systolic frames were identified within the reformatted image sequence. End diastolic images of both ventricles were marked by an operator on the video screen of the computer. A Fourier phase image overlay was used for edge detection of ventricular borders.9 Extracardiac background was subtracted from the precordially registered radioactivity. A detailed description of this correction procedure is given below. The volume curves corrected for background radioactivity were used to determine the left and right ventricular ejection fractions and maximal ejection and filling rates.'0 Fourier analysis of the reformatted image sequence was performed as described previously.-'
Background correction-Count rates registered over the heart chambers that were not emitted by the ventricle's blood pool (background) were determined for the area difference between the end diastolic and the end systolic contours of both ventricles. The background count rates were standardised for the respective end diastolic area of the ventricles. Left and right ventricular count rates were corrected for background radioactivity by subtraction of the normalised count rates derived from the area difference between end diastolic and end systolic left and right ventricular images.
Regurgitation fraction (RF) was calculated from the background corrected count rates according to the method of Sorensen, et al" as modified by Alderson'2: RF(%) = (LV count-1-02 x RV count x LV count) x 100. The calibration factor of [1] [2] had been determined in our laboratory.9 A typical example of end diastolic and end systolic images and their respective regurgitation fractions is shown in Fig. 1 .
We also determined the ratio of regurgitant volume (RGV) to end diastolic volume (EDV). This ratio is a major determinant of the reversibility of functional impairment of compromised left ventricular performance in aortic insufficiency. '3 Control of regurgitation measurements-To check the validity of measuring regurgitation by radionuclide ventriculography 19 patients with coronary heart disease (established by coronary angiography) with normal heart valves and 10 patients with chronic aortic or mitral regurgitation (reflux) were examined before and after valve replacement.9 Virtually no regurgitation was found in patients with coronary heart disease (4 1(3-4)% of left ventricular Fig. 1 
Results
Neither heart rate nor blood pressure were significantly influenced by captopril (Fig. 2) . The left ventricular ejection fraction was also essentially unchanged ( Fig. 3) (ejection fraction 60% before captopril vs 66% after captopril). In contrast the regurgitation fraction decreased from 54% before captopril to 37% after captopril (p<0 0001). The ratio of regurgitant volume to end diastolic volume also showed a significant decrease from 33% before captopril to 24% after captopril (p <0 01) (Fig. 4) 630% ) and significantly reduced concentrations of angiotensin II (range 5-7-42-6%, p < 0-01). There was a 27% decrease of angiotensin converting enzyme activity in peripheral blood (p <0.01). Rate of conversion of angiotensin I to angiotensin II, calculated from blood concentrations, decreased to 50% of that of controls (range 28-86%, p<0-01) (Fig. 5) .
Discussion
Captopril significantly suppresses the reninangiotensin system in patients with aortic regurgitation, as shown by an increase in concentration of angiotensin I and a decrease in concentration of angiotensin II. Accordingly the rate of conversion of angiotensin I to II was significantly reduced and, as expected, the activity of angiotensin converting enzyme was considerably reduced. Reflex tachycardia, which is often seen after treatment with arteriolar dilatators, was not observed after captopril. This finding may be explained by a reduction in the angiotensin II mediated component of sympathetic tone."5 Also, unlike some other vasodilators, captopril does not stimulate the renin-angiotensin system and thus some unfavourable haemodynamic effects are avoided.
Systolic and diastolic blood pressure were essentially unchanged after captopril. In contrast Froer et al noted a slight decrease in systolic blood pressure and little change in diastolic blood pressure.. 6 In their study mean systolic pressure decreased by about 15% after captopril. 6 The different response of systolic blood pressure to captopril in our study may be explained by the fact that our 
